Dermaliq Therapeutics Locks In $15M Series A

Jan 18, 2022•over 3 years ago

Amount Raised

$15 Million

Round Type

series a

Description

Dermaliq Therapeutics Inc, a new Delaware-based pharmaceutical development company, has raised $15 million in Series A financing.

Company Information

Company

Dermaliq Therapeutics

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech